Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market
Holding EVLO?
Track your performance easily

Evelo Biosciences (EVLO) Financial Statements

214 Followers

Evelo Biosciences Financial Overview

Evelo Biosciences's market cap is currently ―. The company's EPS TTM is $-13.35; its P/E ratio is >-0.01; Evelo Biosciences is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.22M$ -19.50M$ -24.09M$ -23.00M$ -29.36M
EBITDA$ -11.05M$ -19.08M$ -23.64M$ -22.43M$ -28.96M
Net Income Common Stockholders$ -12.36M$ -21.10M$ -25.34M$ -23.54M$ -30.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.26M$ 7.62M$ 27.47M$ 47.94M$ 69.05M
Total Assets$ 20.63M$ 20.82M$ 41.97M$ 64.44M$ 86.34M
Total Debt$ 33.95M$ 50.48M$ 50.70M$ 51.14M$ 54.86M
Net Debt$ 16.69M$ 42.86M$ 23.22M$ 3.20M$ -14.20M
Total Liabilities$ 47.33M$ 66.94M$ 69.36M$ 69.43M$ 77.00M
Stockholders Equity$ -26.71M$ -46.13M$ -27.39M$ -4.99M$ 9.33M
Cash Flow-
Free Cash Flow$ -10.46M$ -19.83M$ -20.29M$ -23.42M$ -22.60M
Operating Cash Flow$ -10.41M$ -19.83M$ -20.28M$ -23.19M$ -22.59M
Investing Cash Flow$ 513.00K-$ -12.00K$ -228.00K$ -9.00K
Financing Cash Flow$ 19.22M-$ -199.00K$ 1.74M$ 665.00K
Currency in USD

Evelo Biosciences Earnings and Revenue History

Evelo Biosciences Debt to Assets

Evelo Biosciences Cash Flow

Evelo Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis